Skip to Main Content

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the ongoing layoffs. Despite the downsizing, there is movement. Here are some of the latest comings and goings. Recognize anyone?

And here is our regular feature in which we highlight a different person each week. This time around, we note that Vedanta Biosciences hired Bruce Roberts as chief scientific officer. Previously, he was a group vice president and head of neuro-immunology and immune-mediated disease research at Sanofi Genzyme.

MannKind hired Michael Castagna as chief commercial officer;


Poxel hired Jonae Barnes as senior vice president, investor relations and public relations;

Remedy Pharmaceuticals hired Thomas MacAllister as vice president of R&D and general counsel;


Sound Pharmaceuticals hired Paul Rickey as chief financial officer;

AstraZeneca hired Jennie Younger as vice president of global corporate affairs;

Pfizer named S Sridhar as managing director of its business in India;

Novavax hired Bob Darius as senior vice president, quality operations;

Novavax promoted Dr. Gregory Glenn to president, research and development;

Novavax promoted Amy Fix to senior vice president, regulatory affairs;

Novavax promoted Dr. Louis Fries III to senior vice president and chief medical officer;

Heron Therapeutics hired David Szekeres as senior VP of business development and general counsel;

Kymab named Dr. David Chiswell as chief executive officer;

Medigene says chief financial officer Peter Llewellyn-Davies is leaving;

Transgene hired Dr. Maud Brandely as chief medical officer;

Transgene hired John Felitti as general counsel;

Therapeutic Solutions International hired Dr. Hong Ma as chief scientific officer;

Heart Metabolics hired Dr. Robert Shalwitz as chief operating officer;

Heart Metabolics hired Dr. Mark Midei as executive director, head of cardiology;

Heart Metabolics hired Ian Howes as chief financial officer;

Revance Therapeutics hired Dr. Roman Rubio as senior VP of clinical development;

Allegro Ophthalmics promoted Dr. Vicken Karageozian to president and chief medical officer;

Allegro Ophthalmics promoted John Park to chief scientific officer and VP of manufacturing development.